‘Fizzy’ medicines raise heart risks
Millions of patients worldwide take effervescent, dispersible and soluble medicines. However, in a study recently published in the British Medical Journal, researchers found that taking the maximum daily dose of some “fizzy” versions of some medicines exceeds the recommended daily limits for sodium intake. High salt intake has been linked to high blood pressure, a key risk factor for strokes, heart attacks and other cardiovascular diseases. In the study, the team found that patients taking dispersible forms of drugs had a 16 percent increased risk of a stroke, heart attack or vascular death and were seven times more likely to develop high blood pressure compared with those taking non-high-sodium versions of the same medications.
Patients taking “fizzy” versions of drugs take them in place of the non-high-sodium versions for various reasons. Patients and doctors should be aware of the potential dangers of these drug formulations, and those who take them should take care to limit their dietary salt intake.